During the last session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 35.01 million, with the beta value of the company hitting 0.86. At the end
In today’s recent session, 11.2 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have been traded, and its beta is 0.85. Most recently the company’s
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 55.69 million during the last session, with the company’s beta value hitting 0.85. At the close of
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 26.45 million during the last session, with the company’s beta value hitting 0.85. At the close of
In the latest trading session, 6.27 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.86. With the company’s most recent
In last trading session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) saw 12.83 million shares changing hands with its beta currently measuring 0.87. Company’s recent per share price
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has a beta value of 0.87 and has seen 10.55 million shares traded in the recent trading session. The company, currently
In today’s recent session, 16.36 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have been traded, and its beta is 0.85. Most recently the company’s
In today’s recent session, 4.21 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have been traded, and its beta is 0.84. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
